Press Releases

Filter by Category

All Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Publish Date

August 21, 2025

HDYO Joins C-Path’s Huntington’s Disease Consortium to Amplify Youth Voices in Drug Development

TUCSON, Ariz., August 21, 2025 — Critical Path Institute’s® (C-Path) Huntington’s Disease Regulatory Science Consortium (HD

August 19, 2025

C-Path’s Translational Therapeutics Accelerator Announces $473,000 Grant for Drug Development Project in Primary Sclerosing Cholangitis

TUCSON, Ariz, August 19, 2025 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded a

August 7, 2025

C-Path Awards Translational Therapeutics Accelerator Grant to Advance First-in-Class Antibiotic for Drug-Resistant Lung Infections

TUCSON, Ariz., Aug. 7, 2025 ⎯ Critical Path Institute® (C-Path) announced today that its Translational Therapeutics Accelerator

August 7, 2025

Critical Path Institute’s Translational Therapeutics Accelerator Awards $150,000 Grant to Support a Novel Drug Approach in Hereditary Spastic Paraplegia

TUCSON, Ariz., August 7, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded

July 22, 2025

Join Global Leaders in Shaping the Future of Drug Development at C-Path’s 2025 Global Impact Conference

Stakeholders across the life sciences ecosystem are invited to attend the 2025 C-Path's Global Impact Conference (CGIC), taking...

July 16, 2025

Critical Path Institute Appoints Dr. Aoife Brennan to Board of Directors

C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...

July 16, 2025

C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....

July 9, 2025

C-Path’s Kristen Swingle Named a “Woman Leading the Region” by BizTucson

C-Path) is proud to announce that President and Chief Operating Officer Kristen Swingle, M.S., has been named a 2025 BizTucson..

June 20, 2025

C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury

C-Path, through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain...

June 20, 2025

C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design

C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...

Previous12 3...30 Next